Compare RZLT & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RZLT | VHI |
|---|---|---|
| Founded | 2010 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.9M | 417.5M |
| IPO Year | 2011 | 1994 |
| Metric | RZLT | VHI |
|---|---|---|
| Price | $4.93 | $14.52 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 6 | 1 |
| Target Price | $9.67 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 2.3M | 8.7K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | ★ 26.32 | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $2,077,000,000.00 |
| Revenue This Year | N/A | $33.32 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $205.71 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.07 | $11.44 |
| 52 Week High | $11.46 | $20.00 |
| Indicator | RZLT | VHI |
|---|---|---|
| Relative Strength Index (RSI) | 61.44 | 53.51 |
| Support Level | $2.91 | $13.49 |
| Resistance Level | $9.80 | $14.73 |
| Average True Range (ATR) | 0.34 | 0.66 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 67.31 | 72.55 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.